{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:42:33Z","timestamp":1791268953269,"version":"4.1.0"},"reference-count":49,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Delays in immune recovery after allogeneic hematopoietic stem cell transplantation (allo-HSCT) are associated with increased risks of infection and relapse. IL-7 has a central role in T-cell development and survival and enhances immune recovery in murine models of allo-HSCT. We performed a phase 1 trial of r-hIL-7 (CYT107) in recipients of T-cell depleted allo-HSCTs. Twelve patients were treated with escalating doses of r-hIL-7 administered weekly for 3 weeks. The study drug was well tolerated with only one patient developing acute skin GVHD. At baseline, patients were profoundly lymphopenic. CYT107 induced a doubling in CD4+ and CD8+ T cells. The main effect of IL-7 was an expansion of effector memory T cells, the predominant subset identified in our patients. There was no significant effect on CD4+CD25+FoxP3+ T cells, NK, or B cells. Importantly, we not only saw quantitative increases in T cells after a short course of IL-7 but also demonstrated an increase in functional T cells, including viral-specific T cells that recognize CMV. Enhanced TCR diversity was also observed after treatment. Our results indicate that r-hIL-7 can enhance immune recovery after a T cell\u2013depleted allo-HSCT without causing significant GVHD or other serious toxicity (www.clinicaltrials.gov; NCT00684008).<\/jats:p>","DOI":"10.1182\/blood-2012-06-437236","type":"journal-article","created":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T15:10:10Z","timestamp":1348672210000},"page":"4882-4891","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":201,"title":["Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation"],"prefix":"10.1182","volume":"120","author":[{"given":"Miguel-Angel","family":"Perales","sequence":"first","affiliation":[{"name":"Adult Bone Marrow Transplantation Service, and"},{"name":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Weill Cornell Medical College; New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna D.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Adult Bone Marrow Transplantation Service, and"},{"name":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Weill Cornell Medical College; New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianda","family":"Yuan","sequence":"additional","affiliation":[{"name":"Ludwig Center for Cancer Immunotherapy, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther","family":"Koehne","sequence":"additional","affiliation":[{"name":"Adult Bone Marrow Transplantation Service, and"},{"name":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Weill Cornell Medical College; New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Lechner","sequence":"additional","affiliation":[{"name":"Adult Bone Marrow Transplantation Service, and"},{"name":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza B.","family":"Papadopoulos","sequence":"additional","affiliation":[{"name":"Adult Bone Marrow Transplantation Service, and"},{"name":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Weill Cornell Medical College; New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Young","sequence":"additional","affiliation":[{"name":"Adult Bone Marrow Transplantation Service, and"},{"name":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Weill Cornell Medical College; New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann A.","family":"Jakubowski","sequence":"additional","affiliation":[{"name":"Adult Bone Marrow Transplantation Service, and"},{"name":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Weill Cornell Medical College; New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Zaidi","sequence":"additional","affiliation":[{"name":"Ludwig Center for Cancer Immunotherapy, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humilidad","family":"Gallardo","sequence":"additional","affiliation":[{"name":"Ludwig Center for Cancer Immunotherapy, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailian","family":"Liu","sequence":"additional","affiliation":[{"name":"Ludwig Center for Cancer Immunotherapy, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Rasalan","sequence":"additional","affiliation":[{"name":"Ludwig Center for Cancer Immunotherapy, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jedd D.","family":"Wolchok","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Weill Cornell Medical College; New York, NY;"},{"name":"Ludwig Center for Cancer Immunotherapy, and"},{"name":"Melanoma and Sarcoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Croughs","sequence":"additional","affiliation":[{"name":"Cytheris, Issy Les Moulineaux, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Morre","sequence":"additional","affiliation":[{"name":"Cytheris, Issy Les Moulineaux, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Devlin","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel R. M.","family":"van den Brink","sequence":"additional","affiliation":[{"name":"Adult Bone Marrow Transplantation Service, and"},{"name":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"Weill Cornell Medical College; New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111810223838100_B1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V93.2.467","article-title":"Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions.","volume":"93","author":"Small","year":"1999","journal-title":"Blood"},{"issue":"2","key":"2019111810223838100_B2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1096-8652(199702)54:2<131::AID-AJH6>3.0.CO;2-Y","article-title":"Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T-cell counts.","volume":"54","author":"Storek","year":"1997","journal-title":"Am J Hematol"},{"issue":"8552","key":"2019111810223838100_B3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(87)90763-X","article-title":"Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias.","volume":"2","author":"Maraninchi","year":"1987","journal-title":"Lancet"},{"issue":"13","key":"2019111810223838100_B4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone marrow transplantation.","volume":"336","author":"Curtis","year":"1997","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111810223838100_B5","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood.V91.9.3481","article-title":"Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation.","volume":"91","author":"Powles","year":"1998","journal-title":"Blood"},{"issue":"9","key":"2019111810223838100_B6","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbmt.2009.05.015","article-title":"Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies.","volume":"15","author":"Le Blanc","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2019111810223838100_B7","first-page":"65","article-title":"Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis.","volume":"3","author":"Small","year":"1997","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2019111810223838100_B8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jlb.48.3.205","article-title":"Constitutive expression of interleukin-7 mRNA and production of IL-7 by a cloned murine thymic stromal cell line.","volume":"48","author":"Sakata","year":"1990","journal-title":"J Leukoc Biol"},{"issue":"3","key":"2019111810223838100_B9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.178.3.1109","article-title":"Interleukin 7 is produced by murine and human keratinocytes.","volume":"178","author":"Heufler","year":"1993","journal-title":"J Exp Med"},{"issue":"2","key":"2019111810223838100_B10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0198-8859(97)00230-9","article-title":"Human small intestinal epithelial cells secrete interleukin-7 and differentially express two different interleukin-7 mRNA transcripts: implications for extrathymic T-cell differentiation.","volume":"58","author":"Madrigal-Estebas","year":"1997","journal-title":"Hum Immunol"},{"issue":"1","key":"2019111810223838100_B11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1074-7613(00)80517-8","article-title":"The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression.","volume":"7","author":"von Freeden-Jeffry","year":"1997","journal-title":"Immunity"},{"issue":"7","key":"2019111810223838100_B12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0092-8674(00)80291-3","article-title":"Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice.","volume":"89","author":"Akashi","year":"1997","journal-title":"Cell"},{"issue":"5","key":"2019111810223838100_B13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/80868","article-title":"Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo.","volume":"1","author":"Schluns","year":"2000","journal-title":"Nat Immunol"},{"issue":"7","key":"2019111810223838100_B14","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.4049\/jimmunol.163.7.3662","article-title":"Expression of the transcription factor lung Kruppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo.","volume":"163","author":"Schober","year":"1999","journal-title":"J Immunol"},{"issue":"7","key":"2019111810223838100_B15","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1172\/JCI200317865","article-title":"IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.","volume":"112","author":"Alpdogan","year":"2003","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111810223838100_B16","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1182\/blood.V88.5.1887.1887","article-title":"Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7.","volume":"88","author":"Bolotin","year":"1996","journal-title":"Blood"},{"issue":"12","key":"2019111810223838100_B17","first-page":"1416","article-title":"Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice.","volume":"24","author":"Abdul-Hai","year":"1996","journal-title":"Exp Hematol"},{"issue":"7","key":"2019111810223838100_B18","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.V98.7.2256","article-title":"Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.","volume":"98","author":"Alpdogan","year":"2001","journal-title":"Blood"},{"issue":"5","key":"2019111810223838100_B19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1182\/blood.V97.5.1491","article-title":"IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation.","volume":"97","author":"Mackall","year":"2001","journal-title":"Blood"},{"issue":"3","key":"2019111810223838100_B20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.cji.0000210386.55951.c2","article-title":"IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells.","volume":"29","author":"Rosenberg","year":"2006","journal-title":"J Immunother"},{"issue":"7","key":"2019111810223838100_B21","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20071681","article-title":"Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.","volume":"205","author":"Sport\u00e8s","year":"2008","journal-title":"J Exp Med"},{"issue":"4","key":"2019111810223838100_B22","first-page":"997","article-title":"Enhanced T-cell recovery in HIV-1-infected adults through IL-7 treatment.","volume":"119","author":"Levy","year":"2009","journal-title":"J Clin Invest"},{"issue":"25","key":"2019111810223838100_B23","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1182\/blood-2008-10-186601","article-title":"IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.","volume":"113","author":"Sereti","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111810223838100_B24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/1078-0432.CCR-09-1303","article-title":"Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy.","volume":"16","author":"Sport\u00e8s","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2019111810223838100_B25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/cid\/cis383","article-title":"Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I\/IIa randomized, placebo-controlled, multicenter study.","volume":"55","author":"L\u00e9vy","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2019111810223838100_B26","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2003-05-1433","article-title":"Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy.","volume":"105","author":"Trivedi","year":"2005","journal-title":"Blood"},{"issue":"5","key":"2019111810223838100_B27","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1182\/blood.V99.5.1730","article-title":"Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors.","volume":"99","author":"Koehne","year":"2002","journal-title":"Blood"},{"issue":"9218","key":"2019111810223838100_B28","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0140-6736(00)02293-5","article-title":"Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution [see comments].","volume":"355","author":"Douek","year":"2000","journal-title":"Lancet"},{"issue":"8","key":"2019111810223838100_B29","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/eji.200939480","article-title":"High diversity of the immune repertoire in humanized NOD.SCID.gamma c\u2212\/\u2212 mice.","volume":"39","author":"Marodon","year":"2009","journal-title":"Eur J Immunol"},{"issue":"9","key":"2019111810223838100_B30","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/bmt.2009.371","article-title":"Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.","volume":"45","author":"Perales","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2019111810223838100_B31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.bbmt.2008.02.006","article-title":"Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings.","volume":"14","author":"Castro-Malaspina","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"2019111810223838100_B32","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1182\/blood.V88.9.3513.bloodjournal8893513","article-title":"Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms.","volume":"88","author":"Hamann","year":"1996","journal-title":"Blood"},{"issue":"6","key":"2019111810223838100_B33","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20011756","article-title":"Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood.","volume":"195","author":"Kimmig","year":"2002","journal-title":"J Exp Med"},{"issue":"9","key":"2019111810223838100_B34","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.186.9.1407","article-title":"Phenotypic and functional separation of memory and effector human CD8+ T cells.","volume":"186","author":"Hamann","year":"1997","journal-title":"J Exp Med"},{"issue":"4","key":"2019111810223838100_B35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0167-5699(99)01444-9","article-title":"Faces and phases of human CD8 T-cell development.","volume":"20","author":"Hamann","year":"1999","journal-title":"Immunol Today"},{"issue":"2","key":"2019111810223838100_B36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4049\/jimmunol.166.2.877","article-title":"CCR7 expression and memory T cell diversity in humans.","volume":"166","author":"Campbell","year":"2001","journal-title":"J Immunol"},{"issue":"6716","key":"2019111810223838100_B37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/16717","article-title":"ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.","volume":"397","author":"Hutloff","year":"1999","journal-title":"Nature"},{"issue":"10","key":"2019111810223838100_B38","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1078-0432.CCR-10-0569","article-title":"Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.","volume":"16","author":"Carthon","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2019111810223838100_B39","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.187.8.1295","article-title":"Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen.","volume":"187","author":"Sachsenberg","year":"1998","journal-title":"J Exp Med"},{"issue":"4","key":"2019111810223838100_B40","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4161\/onci.19545","article-title":"Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.","volume":"1","author":"Manuel","year":"2012","journal-title":"OncoImmunology"},{"issue":"5","key":"2019111810223838100_B41","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.4049\/jimmunol.172.5.3328","article-title":"Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease.","volume":"172","author":"Gendelman","year":"2004","journal-title":"J Immunol"},{"issue":"7","key":"2019111810223838100_B42","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2002-04-1082","article-title":"Interleukin 7 worsens graft-versus-host disease.","volume":"100","author":"Sinha","year":"2002","journal-title":"Blood"},{"issue":"2","key":"2019111810223838100_B43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.immuni.2012.02.006","article-title":"Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans.","volume":"36","author":"den Braber","year":"2012","journal-title":"Immunity"},{"issue":"12","key":"2019111810223838100_B44","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1009","article-title":"Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.","volume":"4","author":"Kaech","year":"2003","journal-title":"Nat Immunol"},{"issue":"12","key":"2019111810223838100_B45","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1084\/jem.20030725","article-title":"IL-7 promotes the transition of CD4 effectors to persistent memory cells.","volume":"198","author":"Li","year":"2003","journal-title":"J Exp Med"},{"issue":"5","key":"2019111810223838100_B46","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.4049\/jimmunol.174.5.2900","article-title":"Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.","volume":"174","author":"Paiardini","year":"2005","journal-title":"J Immunol"},{"issue":"12","key":"2019111810223838100_B47","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1073\/pnas.92.12.5491","article-title":"Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division.","volume":"92","author":"Boise","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2019111810223838100_B48","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/jac\/dkq359","article-title":"A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia.","volume":"65","author":"Patel","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2019111810223838100_B49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11523-012-0210-4","article-title":"Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival.","volume":"7","author":"Morre","year":"2012","journal-title":"Target Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/24\/4882\/1361455\/zh805012004882.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/24\/4882\/1361455\/zh805012004882.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T23:30:06Z","timestamp":1687735806000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/24\/4882\/31029\/Recombinant-human-interleukin7-CYT107-promotes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,6]]},"references-count":49,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2012,12,6]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-06-437236","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,6]]}}}